Cell Signaling Technology

Product Pathways - Tyrosine Kinase / Adaptors

Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb #3155

c-fms   CD115   CSF-1   CSF1   Fms proto-oncogene   m-csf   macrophage-colony stimulating factor   mcsf  

No. Size Price
3155S 100 µl ( 10 western blots ) ¥4,050.00 现货查询 购买询价 防伪查询
3155 carrier free & custom formulation / quantityemail request
Applications Dilution Species-Reactivity Sensitivity MW (kDa) Isotype
W 1:1000 Human,Mouse, Endogenous 175 Rabbit IgG
IP 1:200
IHC-P 1:300

Species cross-reactivity is determined by western blot.

Applications Key: W=Western Blotting, IP=Immunoprecipitation, IHC-P=Immunohistochemistry (Paraffin),

Specificity / Sensitivity

Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb detects endogenous levels of M-CSF receptor only when phosphorylated at tyrosine 723. The antibody does not cross-react with related active protein tyrosine kinases.

磷酸化M-CSF 受体(Tyr723)的兔源单克隆抗体(49C10)仅在M-CSF 受体的Tyr723位点磷酸化时能检测到内源的M-CSF 受体蛋白的表达。本抗体不与其它相关激活的酪氨酸激酶发生交叉反应。

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Tyr723 of human M-CSF receptor.

单克隆抗体通过用多肽免疫动物得到,该磷酸化多肽是根据人的M-CSF 受体蛋白Tyr723附近的氨基酸序列合成的。

Western Blotting

Western Blotting

Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb specifically binds to phosphorylated M-CSF receptors, but not other phosphorylated protein tyrosine kinases. Western blot anlysis of extracts from various cell lines expressing different activated protein tyrosine kinases, using Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb (upper). The same membrane was stripped and reprobed with Phospho-Tyrosine Monoclonal Antibody (P-Tyr-100) (lower). 抗磷酸化M-CSF 受体(Tyr723)的兔源单克隆抗体(49C10)能特异结合磷酸化的M-CSF 受体蛋白,但不与其它磷酸化酪氨酸蛋白激酶结合。用抗磷酸化M-CSF 受体(Tyr723)的兔源单克隆抗体(49C10)(上)对表达不同激活酪氨酸蛋白激酶的各种细胞系的提取物进行免疫印迹检测。同一张膜洗脱之后,用抗磷酸化酪氨酸(P-Tyr-100)的单克隆抗体重新检测(下)。

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded FDCP1/fms cells, untreated (left) or mCSF-treated (right), using Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb. 用抗磷酸化M-CSF 受体(Tyr723)的兔源单克隆抗体(49C10)对石蜡包埋的经过(右)或未经(左)mCSF处理的FDCP1/fms细胞进行免疫组化检测。

Flow Cytometry

Flow Cytometry

Flow cytometric analysis of Ba/F3-CSF-1R cells, untreated (blue) or mCSF-treated (green), using Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb compared to a nonspecific negative control antibody (red). 用抗磷酸化M-CSF 受体(Tyr723)的兔源单克隆抗体(49C10)和非特异的阴性对照抗体(红)对经过(绿色)或未经(蓝色)mCSF处理的Ba/F3-CSF-1R细胞进行流式细胞术检测。

Western Blotting

Western Blotting

Western blot analysis of extracts from NKM-1 cells, untreated or treated with a M-CSFR inhibitor, using Phospho-M-CSF Receptor (Tyr723) (49C10) Rabbit mAb (upper) or M-CSF Receptor Antibody #3152 (lower). 用抗磷酸化M-CSF 受体(Tyr723)的兔源单克隆抗体(49C10)(上)或抗M-CSF 受体的抗体#3152(下)对经过或未经M-CSFR抑制剂处理的NKM-1细胞的提取物进行免疫印迹检测。


Macrophage-colony stimulating factor (M-CSF, CSF-1) receptor is an integral membrane tyrosine kinase encoded by the c-fms proto-oncogene. M-CSF receptor is expressed in monocytes (macrophages and their progenitors) and drives growth and development of this blood cell lineage. (1-3). Binding of M-CSF to its receptor induces receptor dimerization, activation and autophosphorylation of cytoplasmic tyrosine residues used as docking sites for SH2-containing signaling proteins (4). There are at least five major tyrosine autophosphorylation sites. Tyr723 (Tyr721 in mouse) is located in the kinase insert (KI) region. Phosphorylated Tyr723 binds the p85 subunit of PI3 kinase as well as PLC-γ 2 (5). Phosphorylation of Tyr809 provides a docking site for Shc (5). Overactivation of this receptor can lead to a malignant phenotype in various cell systems (6). The activated M-CSF receptor has been shown to be a predictor of poor outcome in advanced epithelial ovarian carcinoma (7) and breast cancer (8).

巨噬细胞集落刺激因子(M-CSF, CSF-1)受体是由原癌基因c-fms编码的一种膜嵌合的酪氨酸激酶。M-CSF 受体表达在单核细胞(巨噬细胞及其前体细胞)上并促进这一系列血细胞的生长和发育(1-3)。M-CSF和它的受体结合后会引起受体二聚化、激活、以及细胞质内作为含SH2信号蛋白结合位点的酪氨酸残基自磷酸化(4)。至少有5个主要的酪氨酸自磷酸化位点。Tyr723 (小鼠Tyr721)位于激酶插入(KI)区。磷酸化的Tyr723能够与PI3K激酶的p85亚基以及PLC-γ 2结合(5)。磷酸化的Tyr809能够为Shc提供停泊位点(5)。该受体的过度激活会导致各种细胞体系呈现出恶性特征(6)。激活的M-CSF 受体表明晚期上皮样卵巢癌(7)和乳腺癌预后不良(8)。

  1. Stanley, E.R. et al. (1978) Nature 274, 168-70.
  2. Byrne, P.V. et al. (1981) J Cell Biol 91, 848-53.
  3. Bourette, R.P. and Rohrschneider, L.R. (2000) Growth Factors 17, 155-66.
  4. Novak, U. et al. (1996) Oncogene 13, 2607-13.
  5. Bourette, R.P. et al. (1997) EMBO J 16, 5880-93.
  6. Morley, G.M. et al. (1999) Oncogene 18, 3076-84.
  7. Toy, E.P. et al. (2001) Gynecol Oncol 80, 194-200.
  8. Maher, M.G. et al. (1998) Clin Cancer Res 4, 1851-6.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!


Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

U.S. Patent No. 5,675,063.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.

用户评论 --- 共 0


我要参与评论 :